CORONARY INTERVENTIONS

Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds

EuroIntervention 2018;14:e1040-e1048 published online February 2018 published online e-edition October 2018. DOI: 10.4244/EIJ-D-17-00708

Michael Joner1*, MD; Philipp Ruppelt2, PhD; Philine Zumstein2, MSc; Capucine Lapointe-Corriveau3, MSc; Guy Leclerc3,4, MD; Anna Bulin1, DVM; Maria Isabel Castellanos1, PhD; Eric Wittchow5, PhD; Michael Haude6, MD; Ron Waksman7, MD

1. Deutsches Herzzentrum München und Deutsches Zentrum für Herz-Kreislaufforschung e.V., Munich, Germany; 2. BIOTRONIK AG, Bülach, Switzerland; 3. AccelLAB Inc., Boisbriand, Quebec, Canada; 4. University of Montreal, Montreal, Quebec, Canada; 5. CVPath In

Aims: Because vascular restoration therapy using bioresorbable vascular scaffolds (BRS) remains an appealing concept to restore vasoreactivity, an understanding of biodegradation remains

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

bioabsorbable scaffoldsin-stent restenosispreclinical research

Stents and scaffoldsOther

Share on Facebook Share on Twitter Share on Linkedin